SC912 inhibits AR-V7 activity in castration-resistant prostate cancer by targeting the androgen receptor N-terminal domain

Oncogene, Published online: 26 March 2024; doi:10.1038/s41388-024-02944-2SC912 inhibits AR-V7 activity in castration-resistant prostate cancer by targeting the androgen receptor N-terminal domain

Source: Oncogene - March 26, 2024 Category: Cancer & Oncology Authors: Qianhui Yi Xiaojun Han Henry G. Yu Huei-Yu Chen Dinghong Qiu Jie Su Rongtuan Lin Gerald Batist Jian Hui Wu Source Type: research